| P50 | author | Dale N Gerding | Q63245110 |
| P2860 | cites work | The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile | Q24562382 |
| | Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor | Q24634418 |
| | Molecular characterization of the Clostridium difficile toxin A gene | Q24656092 |
| | Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial | Q29394639 |
| | Cloning of Clostridium difficile toxin B gene and demonstration of high N-terminal homology between toxin A and B. | Q33686152 |
| | Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals | Q33881350 |
| | Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. | Q33889330 |
| | Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube | Q33964412 |
| | Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. | Q33968261 |
| | Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea | Q33973121 |
| | Clostridium difficile and the aetiology of pseudomembranous colitis | Q34058811 |
| | Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro | Q34214675 |
| | Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection | Q34236809 |
| | Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis | Q34247700 |
| | Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis | Q34281870 |
| | Glucosylation of Rho proteins by Clostridium difficile toxin B. | Q34312765 |
| | A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality | Q34472139 |
| | An epidemic, toxin gene-variant strain of Clostridium difficile | Q34472146 |
| | A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity | Q34643123 |
| | Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia | Q34708067 |
| | Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy | Q35039058 |
| | Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture | Q36021240 |
| | Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review | Q36199514 |
| | Biological activities of toxins A and B of Clostridium difficile | Q36438279 |
| | Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile | Q38347728 |
| | Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. | Q38470026 |
| | Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin | Q39463318 |
| | Pseudomembranous colitis: Presence of clostridial toxin | Q39472640 |
| | Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection | Q39760796 |
| | A case-control study of community-associated Clostridium difficile infection | Q39844072 |
| | Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems | Q40188190 |
| | Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. | Q40699567 |
| | Epidemiology of community-acquired Clostridium difficile-associated diarrhea | Q40799083 |
| | Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients | Q40910705 |
| | Nosocomial acquisition of Clostridium difficile infection | Q41877583 |
| | Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin | Q41890836 |
| | Transcriptional analysis of the toxigenic element of Clostridium difficile | Q42652101 |
| | Pseudo-membranous colitis | Q42929200 |
| | Human antibody response to surface layer proteins in Clostridium difficile infection | Q43553287 |
| | Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding | Q43808227 |
| | Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens | Q44770189 |
| | Treatment of Clostridium difficile colitis and diarrhea with vancomycin | Q45093783 |
| | Effect of yogurt on clindamycin-induced Clostridium difficile colitis in hamsters | Q45621538 |
| | Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. | Q45980203 |
| | Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea | Q46376143 |
| | Undescribed toxin in pseudomembranous colitis | Q50191981 |
| | Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. | Q54150684 |
| | INTESTINAL FLORA IN NEW-BORN INFANTS | Q56286565 |
| | Association of Interleukin-8 Polymorphism and Immunoglobulin G Anti–Toxin A in Patients With Clostridium difficile–Associated Diarrhea | Q61833618 |
| | Detection of toxigenic Clostridium difficile in stool specimens by the polymerase chain reaction | Q64135847 |
| | Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial | Q67492785 |
| | Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile | Q67579613 |
| | Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables | Q68065821 |
| | Nosocomial Clostridium difficile colonisation and disease | Q68094486 |
| | Clindamycin-associated colitis. A prospective study | Q68788475 |
| | Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain | Q68988457 |
| | Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients | Q69370183 |
| | Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism | Q69943295 |
| | Lincomycin as a cause of pseudomembranous colitis | Q70004584 |
| | Epidemiology of experimental enterocecitis due to Clostridium difficile | Q71403009 |
| | Antagonism of toxigenic Clostridium difficile by nontoxigenic C. difficile | Q71710550 |
| | Serum antibody response to toxins A and B of Clostridium difficile | Q71831887 |
| | Wide diversity of Clostridium difficile types at a tertiary referral hospital | Q72166954 |
| | Environmental control to reduce transmission of Clostridium difficile | Q73118850 |
| | The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii | Q73118857 |
| | Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea | Q73523895 |
| | Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea | Q74309235 |
| | The epidemiology and typing of Clostridium difficile | Q74661397 |
| | Clostridium difficile toxin expression is inhibited by the novel regulator TcdC | Q80416957 |
| | Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea | Q81400778 |
| | Protection of hamsters against Clostridium difficile ileocaecitis by prior colonisation with non-pathogenic strains | Q93578151 |
| P921 | main subject | Clostridium difficile | Q310543 |
| P304 | page(s) | S2-8 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | International Journal of Antimicrobial Agents | Q15724616 |
| P1476 | title | Clostridium difficile 30 years on: what has, or has not, changed and why? | |
| P478 | volume | 33 Suppl 1 | |